A detailed history of Tower Research Capital LLC (Trc) transactions in Jan One Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,133 shares of JAN stock, worth $2,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,133
Previous 10,719 89.43%
Holding current value
$2,537
Previous $6,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.5 - $2.88 $4,793 - $27,607
-9,586 Reduced 89.43%
1,133 $2,000
Q4 2023

Feb 13, 2024

BUY
$0.3 - $0.66 $7 - $17
26 Added 0.24%
10,719 $6,000
Q3 2023

Nov 14, 2023

BUY
$0.41 - $1.07 $446 - $1,164
1,088 Added 11.33%
10,693 $4,000
Q2 2023

Aug 14, 2023

BUY
$0.87 - $1.2 $1,005 - $1,387
1,156 Added 13.68%
9,605 $10,000
Q1 2023

May 09, 2023

BUY
$1.07 - $1.77 $5,695 - $9,421
5,323 Added 170.28%
8,449 $10,000
Q4 2022

Feb 10, 2023

BUY
$1.37 - $2.12 $4,020 - $6,222
2,935 Added 1536.65%
3,126 $4,000
Q3 2022

Nov 10, 2022

BUY
$2.27 - $3.43 $104 - $157
46 Added 31.72%
191 $0
Q2 2022

Aug 15, 2022

BUY
$2.0 - $4.07 $290 - $590
145 New
145 $0
Q1 2022

May 12, 2022

SELL
$2.5 - $4.25 $3,002 - $5,104
-1,201 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.86 - $6.65 $4,635 - $7,986
1,201 New
1,201 $5,000
Q3 2021

Nov 15, 2021

SELL
$5.98 - $8.0 $11,948 - $15,984
-1,998 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$5.9 - $9.46 $11,788 - $18,901
1,998 New
1,998 $16,000
Q1 2021

May 17, 2021

SELL
$4.47 - $12.99 $16,512 - $47,985
-3,694 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.5 - $5.44 $10,444 - $16,232
2,984 Added 420.28%
3,694 $18,000
Q3 2020

Nov 16, 2020

BUY
$3.07 - $7.79 $2,179 - $5,530
710 New
710 $3,000

Others Institutions Holding JAN

About JanOne Inc.


  • Ticker JAN
  • Exchange NASDAQ
  • Sector Industrials
  • Industry Waste Management
  • Shares Outstandng 3,150,230
  • Market Cap $7.06M
  • Description
  • JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. ...
More about JAN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.